• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

无糖尿病成年人中胰岛自身抗体的患病率

Prevalence of Islet Autoantibodies in Adults Without Diabetes.

作者信息

Pauley Meghan E, Simmons Kimber M, Dong Fran, Yu Liping, Steck Andrea K, Rasmussen Cristy Geno, Frohnert Brigitte I, Rewers Marian J

机构信息

Barbara Davis Center for Diabetes, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.

出版信息

J Endocr Soc. 2025 May 20;9(8):bvaf095. doi: 10.1210/jendso/bvaf095. eCollection 2025 Aug.

DOI:10.1210/jendso/bvaf095
PMID:40496897
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12151016/
Abstract

CONTEXT

Over half of all new cases of type 1 diabetes (T1D) are diagnosed in adults, yet the natural history of adult-onset T1D, particularly in nonfamilial populations, is not fully understood.

OBJECTIVE

This study measured the prevalence of islet autoantibodies (IA) in adults without known diabetes and irrespective of T1D family history from Colorado (USA).

METHODS

The Autoimmunity Screening for Kids study screened for IAs to insulin, glutamic acid decarboxylase (GADA), islet antigen-2, and zinc transporter 8 in 1087 adults without known diabetes [mean age 40.7 years with range 19.6-63.9 years, 63% non-Hispanic White (NHW), 10% with family history of T1D in a first-degree relative, and 78% female] from Colorado. IAs were measured using radiobinding assay and electrochemiluminescence detection methods.

RESULTS

In total, 3.86% of adults screened positive for any IA, 0.55% screened positive for multiple IAs, and 1.75% were positive for a single IA by both detection methods. Compared to NHW, those with Hispanic race/ethnicity were more likely to screen positive for a single IA (relative risk 2.32, 95% confidence interval 1.40, 3.84, = .001), but there was no difference in the risk of screening positive for multiple IAs when comparing across race/ethnicity. GADA was the most prevalent IA, found in 2.67% of adults.

CONCLUSION

IA prevalence was high in this sample of adults without known diabetes from Colorado. Further study is needed to fully characterize the risk of progression to clinical diabetes among adults who screen positive for IAs, particularly in nonfamilial populations.

摘要

背景

超过一半的1型糖尿病(T1D)新发病例在成人中被诊断出来,但成人发病型T1D的自然病程,尤其是在非家族性人群中的自然病程,尚未完全了解。

目的

本研究测量了美国科罗拉多州无已知糖尿病且与T1D家族史无关的成年人中胰岛自身抗体(IA)的患病率。

方法

儿童自身免疫筛查研究对来自科罗拉多州的1087名无已知糖尿病的成年人[平均年龄40.7岁,范围19.6 - 63.9岁,63%为非西班牙裔白人(NHW),10%的一级亲属有T1D家族史,78%为女性]进行了胰岛素、谷氨酸脱羧酶(GADA)、胰岛抗原2和锌转运体8的IA筛查。使用放射结合测定法和电化学发光检测法测量IA。

结果

总体而言,3.86%的成年人任何一种IA筛查呈阳性,0.55%的成年人多种IA筛查呈阳性,两种检测方法均显示1.75%的成年人单一IA呈阳性。与NHW相比,西班牙裔种族/族裔的人单一IA筛查呈阳性的可能性更高(相对风险2.32,95%置信区间1.40,3.84,P = 0.001),但在不同种族/族裔之间比较时,多种IA筛查呈阳性的风险没有差异。GADA是最常见的IA,在2.67%的成年人中被发现。

结论

在科罗拉多州这个无已知糖尿病的成人样本中,IA患病率很高。需要进一步研究以全面描述IA筛查呈阳性的成年人,尤其是非家族性人群中进展为临床糖尿病的风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f20/12151016/930d33a094cf/bvaf095f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f20/12151016/54eecc076261/bvaf095f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f20/12151016/930d33a094cf/bvaf095f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f20/12151016/54eecc076261/bvaf095f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f20/12151016/930d33a094cf/bvaf095f2.jpg

相似文献

1
Prevalence of Islet Autoantibodies in Adults Without Diabetes.无糖尿病成年人中胰岛自身抗体的患病率
J Endocr Soc. 2025 May 20;9(8):bvaf095. doi: 10.1210/jendso/bvaf095. eCollection 2025 Aug.
2
Anti-Islet Autoantibodies in Type 1 Diabetes.1 型糖尿病中的胰岛自身抗体。
Int J Mol Sci. 2023 Jun 11;24(12):10012. doi: 10.3390/ijms241210012.
3
Glutamic acid decarboxylase autoantibodies are dominant but insufficient to identify most Chinese with adult-onset non-insulin requiring autoimmune diabetes: LADA China study 5.谷氨酸脱羧酶自身抗体在成人隐匿性自身免疫性糖尿病(LADA)中占主导地位,但不足以识别大多数中国成年非胰岛素依赖型自身免疫性糖尿病患者:LADA中国研究5。
Acta Diabetol. 2015 Dec;52(6):1121-7. doi: 10.1007/s00592-015-0799-8. Epub 2015 Aug 5.
4
Evaluation of the RSR 3 screen ICA™ and 2 screen ICA™ as screening assays for type 1 diabetes in Sweden.评价 RSR 3 屏幕 ICA™ 和 2 屏幕 ICA™ 作为瑞典 1 型糖尿病的筛查检测方法。
Acta Diabetol. 2022 Jun;59(6):773-781. doi: 10.1007/s00592-022-01856-5. Epub 2022 Feb 26.
5
Enzyme-linked immunosorbent assay of 3 Screen Islet Cell Autoantibody in patients with autoimmune thyroid disease.自身免疫性甲状腺疾病患者3种筛查胰岛细胞自身抗体的酶联免疫吸附测定
World J Diabetes. 2024 May 15;15(5):935-944. doi: 10.4239/wjd.v15.i5.935.
6
Islet Autoantibody Level Distribution in Type 1 Diabetes and Their Association With Genetic and Clinical Characteristics.1 型糖尿病患者胰岛自身抗体水平分布及其与遗传和临床特征的关系。
J Clin Endocrinol Metab. 2022 Nov 25;107(12):e4341-e4349. doi: 10.1210/clinem/dgac507.
7
Identification of tyrosine phosphatase 2(256-760) construct as a new, sensitive marker for the detection of islet autoimmunity in type 2 diabetic patients: the non-insulin requiring autoimmune diabetes (NIRAD) study 2.鉴定酪氨酸磷酸酶2(256 - 760)构建体作为2型糖尿病患者胰岛自身免疫检测的一种新的敏感标志物:非胰岛素依赖型自身免疫性糖尿病(NIRAD)研究2
Diabetes. 2008 May;57(5):1276-83. doi: 10.2337/db07-0874. Epub 2008 Mar 10.
8
Associated autoimmunity in Type 1 Diabetes and latent autoimmune diabetes of adults: The role of glutamic-acid decarboxylase autoantibodies.1 型糖尿病和成人隐匿性自身免疫性糖尿病中的相关自身免疫:谷氨酸脱羧酶自身抗体的作用。
Diabetes Res Clin Pract. 2021 May;175:108847. doi: 10.1016/j.diabres.2021.108847. Epub 2021 May 1.
9
Detection of Islet Autoantibodies in Whole Blood by Antibody Detection by Agglutination-PCR (ADAP) Technology Is Sensitive and Suitable for General Population Screening Programs.采用凝集聚合酶链反应(ADAP)技术检测全血中的胰岛自身抗体灵敏且适用于一般人群筛查项目。
Pediatr Diabetes. 2024 Mar 14;2024:4238394. doi: 10.1155/2024/4238394. eCollection 2024.
10
Clinical phenotype and beta-cell autoimmunity in Italian patients with adult-onset diabetes.意大利成年发病型糖尿病患者的临床表型与β细胞自身免疫
Eur J Endocrinol. 2006 Mar;154(3):441-7. doi: 10.1530/eje.1.02115.

本文引用的文献

1
Consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes.胰岛自身抗体阳性的 3 期 1 型糖尿病前阶段患者监测的共识指南。
Diabetologia. 2024 Sep;67(9):1731-1759. doi: 10.1007/s00125-024-06205-5.
2
Islet autoantibodies as precision diagnostic tools to characterize heterogeneity in type 1 diabetes: a systematic review.胰岛自身抗体作为精准诊断工具用于表征1型糖尿病的异质性:一项系统综述
Commun Med (Lond). 2024 Apr 6;4(1):66. doi: 10.1038/s43856-024-00478-y.
3
Anxiety and Risk Perception in Parents of Children Identified by Population Screening as High Risk for Type 1 Diabetes.
在通过人群筛查确定为 1 型糖尿病高危的儿童的父母中,焦虑和风险感知。
Diabetes Care. 2023 Dec 1;46(12):2155-2161. doi: 10.2337/dc23-0350.
4
Screening and Prevention of Type 1 Diabetes: Where Are We?1 型糖尿病的筛查与预防:我们现在处于什么位置?
J Clin Endocrinol Metab. 2023 Nov 17;108(12):3067-3079. doi: 10.1210/clinem/dgad328.
5
Effective assay technologies fit for large-scale population screening of type 1 diabetes.适用于1型糖尿病大规模人群筛查的有效检测技术。
Front Clin Diabetes Healthc. 2023 Jan 23;3:1034698. doi: 10.3389/fcdhc.2022.1034698. eCollection 2022.
6
Islet Autoantibody Standardization Program: interlaboratory comparison of insulin autoantibody assay performance in 2018 and 2020 workshops.胰岛自身抗体标准化项目:2018 年和 2020 年研讨会中胰岛素自身抗体检测性能的实验室间比较。
Diabetologia. 2023 May;66(5):897-912. doi: 10.1007/s00125-023-05877-9. Epub 2023 Feb 10.
7
Teplizumab approval for type 1 diabetes in the USA.替普珠单抗在美国获批用于1型糖尿病。
Lancet Diabetes Endocrinol. 2023 Feb;11(2):76-77. doi: 10.1016/S2213-8587(22)00390-4. Epub 2023 Jan 6.
8
Global incidence, prevalence, and mortality of type 1 diabetes in 2021 with projection to 2040: a modelling study.2021 年全球 1 型糖尿病发病率、患病率和死亡率,并预测至 2040 年:一项建模研究。
Lancet Diabetes Endocrinol. 2022 Oct;10(10):741-760. doi: 10.1016/S2213-8587(22)00218-2. Epub 2022 Sep 13.
9
Characterising the age-dependent effects of risk factors on type 1 diabetes progression.描述危险因素对 1 型糖尿病进展的年龄依赖性影响。
Diabetologia. 2022 Apr;65(4):684-694. doi: 10.1007/s00125-021-05647-5. Epub 2022 Jan 18.
10
CGM Metrics Predict Imminent Progression to Type 1 Diabetes: Autoimmunity Screening for Kids (ASK) Study.CGM 指标预测 1 型糖尿病的即将发生:儿童自身免疫筛查(ASK)研究。
Diabetes Care. 2022 Feb 1;45(2):365-371. doi: 10.2337/dc21-0602.